Skip to content

Relation between androgen hormone with sexual function in women use LD

Relation between androgen hormone with sexual function in women use LD attending in selected Health centers of shiraz university of medical sciences in 2012-2013

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013070213846N1
Enrollment
89
Registered
2013-09-22
Start date
2013-08-12
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

female sexual dysfunction. Behavioural syndromes associated with physiological disturbances and physical factors

Interventions

Intervention with oral contraceptive(low dose) for 3 month /daily.
Treatment - Drugs
Intervention with oral contraceptive(low dose) for 3 month /daily

Sponsors

Vice chancellor for Research, Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: willingness to participate; married woman with age between 18-35 years old; having score 28 or more of Female Sexual Function Index; not pregnant; not having breast feeding; no history of heart disease and vascular disease (the patient's medical records); no history of uncontrolled hypertension and hypotension; no history of liver dysfunction; not taking any medications that affect sexual function (specially common antidepressant); not having migraine and ulcer; don’t use alcohol and cigarette; not sexual function disorder; regular mensturation. Exclusion criteria : taking hormone pills particulary OCP; taking alchohl or tobacco; history of active peptic ulcer disease ; history of headaches including migraines; history of dysparunia or vaginismus.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Female sexual dysfunction. Timepoint: At the start of intervention- After 3 months of intervention. Method of measurement: Female Sexual Function Index Questionnaire.

Secondary

MeasureTime frame
Improvement of sexual function. Timepoint: At the start of intervention- After 3 months of intervention. Method of measurement: Female Sexual Function Index Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKhadije Abdali

Fatemeh College of Nursing And Midwifery,Shiraz University of Medical Sciences

abdalikh@sums.ac.ir+98 71 1647 4254

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026